| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.4 |